Month: February 2021

FOSTER CITY, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases, today announced the closing of the Company’s initial public offering of 7,500,000 shares of common stock at a public offering price of $17.00 per share, along with   the exercise in full by the underwriters of their option to purchase an additional 1,125,000 shares of common stock. The exercise of the underwriters’ option to purchase additional shares is expected to close on February 12, 2021, subject to customary closing conditions. After giving effect to the full exercise by the underwriters...

Ørsted and PGE Polska Grupa Energetyczna S.A. (‘PGE’) have signed an agreement to form a 50/50 joint venture for the development, construction and operation of two offshore wind projects in the Baltic Sea with a total potential capacity of up to 2.5 GW.Ørsted will subscribe for new shares representing 50% of the total share capital in PGE’s two offshore wind projects, Elektrownia Wiatrowa Baltica-3 sp. z o.o. (‘Baltica 3’) and Elektrownia Wiatrowa Baltica-2 sp z o.o. (‘Baltica 2).  Baltica 3 has a capacity of approximately 1 GW and Baltica 2 has a capacity of approximately 1.5 GW. The subscription price for the newly issued shares in Baltica 2 and 3 will amount to a total of PLN 657 million.Both projects are eligible to be included in Poland’s 2021 offshore wind allocation round, where a total of 5.9 GW is expected to be awarded. Baltica...

Ørsted og PGE Polska Grupa Energetyczna S.A. (‘PGE’) har underskrevet en aftale om at etablere et 50/50-joint venture, der skal udvikle, opføre og drive to havvindprojekter i Østersøen, som tilsammen har en potentiel kapacitet på op til 2,5 GW.Ørsted vil tegne nye aktier, der udgør 50 % af den samlede aktiekapital i PGE’s to havvindprojekter Elektrownia Wiatrowa Baltica-3 sp. z o.o. (‘Baltica 3’) og Elektrownia Wiatrowa Baltica-2 sp z o.o. (‘Baltica 2‘). Baltica 3 har en kapacitet på ca. 1 GW, og Baltica 2 har en kapacitet på ca. 1,5 GW. Tegningskursen for de nyligt udstedte aktier i Baltica 2 og 3 vil beløbe sig til i alt PLN 657 millioner.Begge projekter er berettiget til at blive inkluderet i Polens tildelingsrunde for havvindprojekter i 2021, hvor en kapacitet på i alt 5,9 GW forventes tildelt. Baltica 3 er det mest fremskredne...

HARTSVILLE, S.C., Feb. 10, 2021 (GLOBE NEWSWIRE) — The Board of Directors of Sonoco (NYSE: SON) today increased its quarterly common stock dividend by approximately 5 percent to $0.45 per share from the previous quarterly distribution of $0.43 per share. The dividend will be paid on March 10, 2021, to shareholders of record as of February 24, 2021.With this increase, Sonoco’s annual dividend payout moves to $1.80 per share from $1.72 per share, a 4.7 percent increase. Future quarterly declarations and the establishment of future record and payment dates are subject to the final determination by Sonoco’s Board of Directors.According to Howard Coker, president and chief executive officer, this is the 383rd consecutive quarter, dating back to 1925, that the Company has paid dividends to shareholders, and is the 38th consecutive year...

SASKATOON, Saskatchewan, Feb. 10, 2021 (GLOBE NEWSWIRE) — Cameco (TSX: CCO; NYSE: CCJ) today reported its consolidated financial and operating results for the fourth quarter and year ended December 31, 2020 in accordance with International Financial Reporting Standards (IFRS).“As we head into 2021, we remain positive about the long-term fundamentals for the uranium market,” said Tim Gitzel, Cameco’s president and CEO. “Around the globe, we are seeing an increasing focus on electrification for various reasons. There are those that are installing baseload power, those who are looking for a reliable replacement to fossil fuel sources, and finally, there is new demand for things like the electrification of transportation. This is occurring precisely at the same time countries and companies around the world are making net-zero commitments,...

Net sales increased 4.8% for the quarter and 8.0% year-to-dateHigher gross profit for the quarter and year-to-date periodsCompany ended the quarter with a $3.7 million cash balanceBoard declares a quarterly dividend of $0.08 per shareGONZALES, La., Feb. 10, 2021 (GLOBE NEWSWIRE) — Crown Crafts, Inc. (NASDAQ-CM: CRWS) (the “Company”) today reported results for the third quarter of fiscal year 2021, which ended December 27, 2020.“Demand for our products was strong in the third quarter and has remained so throughout the first nine months of fiscal 2021,” said E. Randall Chestnut, Chairman and Chief Executive Officer. “Our financial performance reflects the success of our strategies and the continued popularity of our product portfolio, which has remained aligned with consumer preferences even in these most challenging times,” Chestnut...

VIRGINIA CITY, Nev., Feb. 10, 2021 (GLOBE NEWSWIRE) — Comstock Mining Inc. (NYSE: LODE) (“Comstock” and the “Company”) and Mercury Clean Up LLC (“MCU”), announced today that construction is nearly complete in their Clean Mercury Remediation Technologies (“CMRT”) joint venture, representing the first mercury remediation and gold extraction facility in the province of Davao D’ Oro, Philippines, with initial operations launching next week.Artisanal and Small-Scale Gold Mining (ASGM) DilemmaMercury‐dependent ASGM uses a process known as amalgamation to dissolve gold from natural deposits. The amalgam is then typically isolated by hand and then heated to distill the mercury and isolate the gold. Problematically, mercury is hazardous to human health and the environment, where residual ASGM wastes contaminate water and soil and ultimately...

AUSTIN, Texas, Feb. 10, 2021 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company” or “Cassava Sciences”), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced that it has entered into a definitive agreement with several healthcare-focused and other institutional investors for the purchase of 4,081,633 shares of its common stock, at a purchase price per share of $49.00, for gross proceeds of approximately $200.0 million, in a registered direct offering. The closing of the offering is expected to occur on or about February 12, 2021, subject to the satisfaction of customary closing conditions.H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.Cassava Sciences intends to use the net proceeds, if any, from this offering for working capital and general...